
Stryker (SYK) Stock Forecast & Price Target
Stryker (SYK) Analyst Ratings
Bulls say
Stryker is poised for continued success due to its strong positioning in the large-cap MedTech industry and its steady growth in orthopedic end-markets. The company's positive outlook is supported by its diversified product portfolio, strong demand for its capital products, and its presence in attractive end-markets. While the recent cyberattack may have caused some disruption, it is likely to be recuperated in the second half of the year. Furthermore, Stryker's presence in the international market also provides potential for future growth. However, potential risks to this positive outlook include slower-than-expected adoption within the ASC setting, potential declines in growth from mature product cycles, and increasing competition from orthopedic robotic systems. Despite these risks, Stryker remains well-positioned for future success and offers a positive risk/reward profile for investors.
Bears say
Stryker is a leader in the medical technology industry with a strong competitive position in reconstructive orthopedic implants and operating room equipment. However, slowing momentum from recent product cycles and potential disruptions from a recent cyberattack may limit near-term performance. Furthermore, a lack of execution related to strategic M&A and slower-than-expected adoption within the ASC setting create downside risks to Stryker’s long-term growth potential. As such, the fundamental reasons behind our negative outlook are the potential for slower growth and execution issues, which could impact the company’s financial performance and investor sentiment.
This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.
Stryker (SYK) Analyst Forecast & Price Prediction
Start investing in Stryker (SYK)
Order type
Buy in
Order amount
Est. shares
0 shares